Atopy and Frequency of Exacerbation in Chronic Obstructive Pulmonary Disease Patients
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age40-70
SponsorMansoura University Hospital
About this trial
Chronic Obstructive Pulmonary Disease (COPD) is a heterogeneous lung condition characterized by chronic respiratory symptoms (dyspnea, cough, sputum production and/or exacerbations) due to abnormalities of airways (bronchitis, bronchiolitis) and/or alveoli (emphysema) that cause persistent, often progressive, airflow obstruction.
The presence of non-fully reversible airflow obstruction (FEV1/FVC \< 0.7 post-bronchodilation) measured by spirometry confirms the diagnosis of COPD
Eligibility criteria
Qualifiers
Adults aged 40-70 years diagnosed with COPD according to the Global Initiative for Chronic Obstructive Lung Disease (GOLD) 2024 criteria
Disqualifiers
Patients with known allergic diseases before enrollment
Patients with associated other chronic respiratory disorders
Patients with significant comorbidities that could influence respiratory function.
Recent respiratory infections or use of systemic corticosteroids within the last month before enrollment.
Trial design
Treatments tested in this trial
- Skin prick test
Treatment groups
50 Participants
are divided into 1 treatment groupSponsors and collaborators
Source ClinicalTrials.gov